Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance Find Stocks Now
Close

Poolbeg Pharma PLC (POLB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
11.50 +0.95    +9.00%
24/04 - Closed. Currency in GBP ( Disclaimer )
  • Volume: 4,654,941
  • Bid/Ask: 10.70 / 11.70
  • Day's Range: 11.30 - 12.00
Type:  Equity
Market:  United Kingdom
ISIN:  GB00BKPG7Z60 
SEDOL:  BKPG7Z6
Poolbeg Pharma 11.50 +0.95 +9.00%

Poolbeg Pharma Company Profile

 
Read the Poolbeg Pharma PLC company profile to learn more about the business and the management team. View Poolbeg Pharma PLC facts about employee data, company products and services, and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

7

Equity Type

ORD

Poolbeg Pharma Plc is a United Kingdom-based biopharmaceutical company. The Company is engaged in the development of medicines to address the unmet need for infectious and other prevalent diseases. The Company is involved in the development of a range of pharmaceutical products. Its product pipeline includes POLB 001, POLB 002 and POLB 003. The Company is focused on developing two oral delivery platforms targeting areas of unmet medical need that include oral vaccine delivery, which is delivering immune-stimulating antigens to specific areas of the gut using encapsulation technologies, and oral delivery of metabolic disease treatments, which is a delivery system that offers generally regarded as safe (GRAS) approved solution for the oral delivery of GLP-1/metabolic peptide cargo to specific areas of the gut and into systemic circulation for the treatment of diabetes and other metabolic diseases. It uses artificial intelligence to identify infectious disease drug targets and treatments.

Contact Information

Address Queen Mary BioEnterprises Innovation Ctr 42 New Road
London, E1 2AX
United Kingdom
Phone 44 20 7183 1499
Fax -

Top Executives

Name Age Since Title
Edward Gibson 50 2021 Independent Non-Executive Director
Elaine Sullivan 62 - Member of Scientific Advisory Board
Daniel F. Hoft - 2021 Member of Scientific Advisory Board
Luke O’Neill 59 2021 Independent Non-Executive Director & Member of Scientific Advisory Board
Brendan Mary Buckley 73 2022 Member of Scientific Advisory Board & Independent Non Executive Director
Ian O'Connell 37 2021 CFO & Director
Jeremy Skillington 53 2021 CEO & Director
Cathal Martin Friel 59 2021 Executive Chairman of The Board
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

POLB Price Commentary

Write your thoughts about Poolbeg Pharma PLC
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Sparky JC
Sparky JC Dec 15, 2022 10:00
Saved. See Saved Items.
This comment has already been saved in your Saved Items
looking good here for 2023, bigs deals coming
virg smit
virg smit Mar 20, 2022 22:10
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I got the extra dividends wrong -just waiting to see what they come up with-if anything-prior to the 18/19? April release date on rht POLB dividend share-
virg smit
virg smit Jul 29, 2021 12:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This share has some interesting products in the pipeline .It is been devolved out of Open Orphan.Well worth researching both companies-Orph gave its shareholders an exceptional dividend in POLB and is ue to announce a further 2 if not 3 dividends including a cash one before year end.
Louise Lathwell
Louise Lathwell Jul 29, 2021 12:49
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Looks a load of rubbish like open orphan but what do i know
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email